• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌连续评估变化的放射学估计(PRECISE)磁共振成像评分预测1级前列腺癌主动监测的临床结局

Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer.

作者信息

Bhanji Yasin, Mamawala Mufaddal, de la Calle Claire M, Landis Patricia, Epstein Jonathan I, Simopoulos Demetrios N, Macura Katarzyna J, Pavlovich Christian P

机构信息

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Urology. 2023 Oct;180:194-199. doi: 10.1016/j.urology.2023.07.019. Epub 2023 Aug 1.

DOI:10.1016/j.urology.2023.07.019
PMID:37536582
Abstract

OBJECTIVE

To determine whether radiological change on serial multiparametric magnetic resonance imaging scored using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Scoring system predicts grade reclassification (GR) at surveillance biopsy in men on active surveillance (AS) with Grade Group 1 (GG1) prostate cancer (PCa).

METHODS

We retrospectively reviewed records of 255 men with low-risk PCa on AS with magnetic resonance imaging (MRI)-informed diagnostic and confirmatory biopsies and studied the subset who had surveillance biopsies (n = 163) within 6months of an interval MRI.

RESULTS

We studied 309 PRECISE scores in 255 men. 14% demonstrated radiological progression (PRECISE 4-5) on interval MRI performed within 24months, compared to 34% of those whose interval MRI was performed at a >3-year interval (P = .002). 28% (46/163) of men undergoing surveillance biopsy experienced GR to ≥ GG2 PCa. There was no significant increase in the rate of GR with increasing PRECISE score (PRECISE 1-2: 24%, PRECISE 3: 23%, PRECISE 4-5: 38%; P = .11). There was a significant increase in the rate of GR with increasing PI-RADS score (P < .05). On multivariable analysis, a PI-RADS score of 4-5 was significantly associated with GR compared to men who had a highest PI-RADS ≤3 (OR=1.98 [95% CI: 1.45-3.09, P = .01]).

CONCLUSION

In a low-risk AS cohort with limited follow-up, a patient's highest PI-RADS rather than their PRECISE score on interval MRI was predictive of GR on surveillance biopsy.

摘要

目的

确定使用前列腺癌序列评估放射学变化评估(PRECISE)评分系统对连续多参数磁共振成像进行的放射学变化是否能预测接受主动监测(AS)的1级(GG1)前列腺癌(PCa)男性患者在监测活检时的分级重新分类(GR)。

方法

我们回顾性分析了255例接受AS的低风险PCa男性患者的记录,这些患者进行了磁共振成像(MRI)引导下的诊断性和确认性活检,并研究了在间隔MRI后6个月内进行监测活检的亚组(n = 163)。

结果

我们研究了255例男性患者的309个PRECISE评分。在24个月内进行的间隔MRI中,14%表现出放射学进展(PRECISE 4 - 5),而间隔MRI在3年以上进行的患者中这一比例为34%(P = 0.002)。接受监测活检的男性中有28%(46/163)经历了GR至≥GG2 PCa。随着PRECISE评分增加,GR发生率无显著增加(PRECISE 1 - 2:24%,PRECISE 3:23%,PRECISE 4 - 5:38%;P = 0.11)。随着PI - RADS评分增加,GR发生率显著增加(P < 0.05)。多变量分析显示,与最高PI - RADS≤3的男性相比,PI - RADS评分为4 - 5与GR显著相关(OR = 1.98 [95% CI:1.45 - 3.09,P = 0.01])。

结论

在随访有限的低风险AS队列中,患者间隔MRI上的最高PI - RADS而非PRECISE评分可预测监测活检时的GR。

相似文献

1
Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer.前列腺癌连续评估变化的放射学估计(PRECISE)磁共振成像评分预测1级前列腺癌主动监测的临床结局
Urology. 2023 Oct;180:194-199. doi: 10.1016/j.urology.2023.07.019. Epub 2023 Aug 1.
2
Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.在前列腺癌主动监测的男性中,连续前列腺多参数磁共振成像的诊断准确性和预后价值。
Eur Urol Oncol. 2022 Oct;5(5):537-543. doi: 10.1016/j.euo.2020.11.007. Epub 2021 Jan 19.
3
Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?在主动监测的男性中,通过连续前列腺磁共振成像和重复活检进行前列腺癌升级:是否仍需要确认性活检?
BJU Int. 2020 Jul;126(1):124-132. doi: 10.1111/bju.15065. Epub 2020 Apr 22.
4
Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.前列腺癌主动监测男性磁共振成像报告中连续评估评分变化的放射学评估在临床中的应用
Eur Urol Open Sci. 2023 Sep 11;56:39-46. doi: 10.1016/j.euros.2023.08.006. eCollection 2023 Oct.
5
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance.应用前列腺癌影像学改变评估标准预测主动监测患者前列腺癌进展的磁共振成像改变
Eur Urol Oncol. 2021 Apr;4(2):227-234. doi: 10.1016/j.euo.2020.09.004. Epub 2020 Oct 21.
6
Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.使用前列腺癌影像学改变连续评估标准和 MRI/经直肠超声融合技术以及经会阴饱和活检,对主动监测患者进行选择的标准化磁共振成像报告。
Eur Urol Focus. 2021 Jan;7(1):102-110. doi: 10.1016/j.euf.2019.03.001. Epub 2019 Mar 13.
7
Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group Than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-ultrasound Fusion Targeted Biopsies.在多参数前列腺磁共振成像-超声融合靶向活检中,前列腺癌基因组分类器与Gleason分级组的相关性比前列腺影像报告和数据系统评分更强。
Urology. 2019 Mar;125:64-72. doi: 10.1016/j.urology.2018.12.001. Epub 2018 Dec 12.
8
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?多参数磁共振成像与临床变量:预测主动监测患者重新分类的最佳组合是什么?
Prostate Int. 2020 Dec;8(4):167-172. doi: 10.1016/j.prnil.2020.05.003. Epub 2020 May 28.
9
Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.多参数磁共振成像有助于在前列腺癌主动监测期间进行重新分类。
BJU Int. 2021 Jun;127(6):712-721. doi: 10.1111/bju.15272. Epub 2020 Dec 10.
10
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?多参数磁共振成像在主动监测方案纳入患者随访中的应用。PSA 密度能否区分不同再分类风险的患者?
Clin Genitourin Cancer. 2020 Dec;18(6):e698-e704. doi: 10.1016/j.clgc.2020.04.006. Epub 2020 May 4.

引用本文的文献

1
Magnetic resonance imaging for long-term active surveillance biopsy decision-making.用于长期主动监测活检决策的磁共振成像
BJU Int. 2025 Sep;136(3):500-506. doi: 10.1111/bju.16798. Epub 2025 May 29.
2
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study.在加那利前列腺主动监测研究中,对1级前列腺癌患者诊断后第二次监测活检时进行的磁共振成像
J Urol. 2025 Sep;214(3):251-258. doi: 10.1097/JU.0000000000004592. Epub 2025 Apr 30.
3
MRI and active surveillance: thoughts from across the pond.
磁共振成像与主动监测:来自大洋彼岸的思考
Eur Radiol. 2025 Apr;35(4):2157-2169. doi: 10.1007/s00330-024-10866-6. Epub 2024 Sep 12.
4
Is MRI ready to replace biopsy during active surveillance?磁共振成像(MRI)在主动监测期间是否已准备好替代活检?
Eur Radiol. 2024 Dec;34(12):7716-7727. doi: 10.1007/s00330-024-10863-9. Epub 2024 Jul 4.
5
Longitudinal evaluation of MRI findings, including quantitative apparent diffusion coefficient values, might be necessary to predict disease progression in patients with prostate cancer on active surveillance.对磁共振成像(MRI)结果进行纵向评估,包括定量表观扩散系数值,对于预测接受主动监测的前列腺癌患者的疾病进展可能是必要的。
World J Urol. 2024 Mar 26;42(1):191. doi: 10.1007/s00345-024-04932-3.